REVIEW
Add like
Add dislike
Add to saved papers

Common dermatologic infections in athletes and return-to-play guidelines.

Although the usual perspective on return to play for athletes is recovery from injury, an unheralded aspect on return to play involves potentially contagious skin infections. An estimated 8.5% of health conditions and injuries related to high school sports and 21% of health conditions and injuries related to college sports involve infectious diseases of the skin. In about half of these cases, the head, face, or neck is affected. The infectious agents are common microorganisms, including methicillin-resistant and methicillin-sensitive Staphylococcus and Streptococcus bacteria, herpes viruses, and tinea fungi. The challenge for physicians is to provide proper treatment to patients within the return-to-play guidelines of a sport's governing body, resulting in rapid resolution of the condition, minimization of time spent out of the sport, and minimization of communicable spread of the disease.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app